# Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides.

> **NCT00186537** · NA · COMPLETED · sponsor: **Stanford University** · enrollment: 47 (actual)

## Conditions studied

- Insulin Resistance
- Hypertriglyceridemia

## Interventions

- **DRUG:** Rosiglitazone
- **DRUG:** Fenofibrate
- **BEHAVIORAL:** Weight Loss

## Key facts

- **NCT ID:** NCT00186537
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2017-01-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00186537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00186537, "Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides.". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00186537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*